.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Federal Trade Commission
Express Scripts
McKinsey
Harvard Business School
Boehringer Ingelheim
Cipla
Johnson and Johnson
McKesson

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202071

« Back to Dashboard
NDA 202071 describes POLYETHYLENE GLYCOL 3350, which is a drug marketed by Nuvo Pharm Inc, Nexgen Pharma Inc, Nexgen Pharma, Par Pharm, Mylan, Strides Pharma, Breckenridge Pharm, Teva Pharms, Ani Pharms Inc, Paddock Llc, Raritan Pharms Inc, Novel Labs Inc, and Perrigo R And D, and is included in fifteen NDAs. It is available from sixty-seven suppliers. Additional details are available on the POLYETHYLENE GLYCOL 3350 profile page.

The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

Summary for NDA: 202071

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 202071

Suppliers and Packaging for NDA: 202071

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL 202071 ANDA Emcure Pharmaceuticals USA Inc. 14539-150 14539-150-20 30 POWDER, FOR SOLUTION in 1 BOTTLE (14539-150-20)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:FOR SOLUTION;ORALStrength17GM/SCOOPFUL
Approval Date:Dec 28, 2012TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
Queensland Health
QuintilesIMS
Medtronic
Accenture
Argus Health
McKesson
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot